Why Choose Us?
Protheragen PawDiscover is a company dedicated to pet disease research and drug development. We offer clients comprehensive, end to-end drug development services, spanning from building pet disease models, screening and optimizing drug candidates based on species characteristics, conducting rigorous preclinical studies and clinical trials compliant with veterinary drug regulations, all the way to final regulatory approval. We are committed to helping clients mitigate R&D risks and accelerate the time-to-market for pet drugs.
Core Techniques
Using machine learning and deep learning algorithms, this platform mines vast amounts of chemical and biological data to accurately predict compound-target interactions and optimize drug physicochemical properties, thereby accelerating lead compound discovery and optimization.
Equipped with advanced automated liquid handling systems and high-speed detection instruments, this platform enables rapid activity and toxicity screening of tens of thousands to hundreds of thousands of compounds within a single day, efficiently identifying promising hit compounds for development.
Through the workflow of animal immunization, cell fusion, and monoclonal screening, this platform develops highly specific therapeutic antibodies for pets. It preserves the advantage of native heavy-light chain pairing, making it suitable for complex antigen targets and accelerating monoclonal antibody candidate discovery.
Equipped with advanced automated liquid handling systems and high-speed detection instruments, this platform enables rapid activity and toxicity screening of tens of thousands to hundreds of thousands of compounds within a single day, efficiently identifying promising hit compounds for development
Applying flow chemistry, catalytic conversion, and solvent substitution technologies, this platform reduces synthetic steps and waste generation. It ensures small-molecule drug R&D aligns with sustainable principles, lowers environmental footprint, and supports green process development.
We have established multiple disease models for canines and felines that mimic real pathological environments. These enable precise evaluation of drug efficacy and safety, ensuring accurate prediction of pet responses to medication.
Our Services
We deeply understand the unique challenges of pet drug development and can provide tailored services aligned with your specific requirements.
We Are Ready!